PV
Palvella Therapeutics, Inc.
PVLA · NASDAQ
$151.22 -0.98% (-$1.50)
1M -1.50%
Market Cap $2.17B
P/E Ratio -
Div. Yield -
ROE 47.84%
Piotroski F-Score Weak
3/9Valuation
0 /100
Expensive P/B 10.00x
P/E N/A
P/FFO N/A
Growth
-
N/A EPS growth N/A
Book val. growth N/A
Rev. growth N/A
Profitability
-
N/A Gross margin N/A
FCF margin N/A
Net margin N/A
Quality
0 /100
Poor ROIC 23.89%
Asset turnover 0.00x
ROE 47.84%
Debt
69 /100
Low Debt/Equity 0.00x
Int. coverage -7.92x
Current ratio 21.18x
Stability
19 /100
Unstable Beta -0.17x
Profitable years 0
EPS volatility 154.66%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o PVLA
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Wesley H. Kaupinen
Employees
29
Headquarters
Wayne
Prihajajoči dogodki
10 NOV.
Earnings
Upcoming earnings report